Mark C. Warburton
Direktor/Vorstandsmitglied bei Apex Molecular Ltd.
Profil
Mark C.
Warburton is a Non-Executive Director at Apex Molecular Ltd.
He was a Non-Executive Director at LSL Property Services Plc from 2006 to 2009.
He was also the COO, Secretary, Legal Counsel & IR Contact at Cyprotex Ltd.
from 2012 to 2017.
Additionally, he worked at Addleshaw Booth & Co. from 2004 to 2007.
Aktive Positionen von Mark C. Warburton
| Unternehmen | Position | Beginn |
|---|---|---|
Apex Molecular Ltd.
 Apex Molecular Ltd. BiotechnologyHealth Technology Apex Molecular Ltd. provides chemistry research and experimental development services. Its services include custom/contract synthesis, targeted library synthesis, process optimisation and supply chain management. The company was founded in 2011 and is headquartered in Cheshire, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Mark C. Warburton
| Unternehmen | Position | Ende |
|---|---|---|
| CYPROTEX PLC | Geschäftsführer | 30.06.2017 |
| LSL PROPERTY SERVICES PLC | Direktor/Vorstandsmitglied | 01.06.2009 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LSL PROPERTY SERVICES PLC | Finance |
| Private Unternehmen | 2 |
|---|---|
Cyprotex Ltd.
 Cyprotex Ltd. Miscellaneous Commercial ServicesCommercial Services Cyprotex Ltd. provides pharmaceutical research and development services. It offers ADME and pharmacokinetic, Biosciences, in vitro skin and ocular testing, physicochemical profiling, in vitro toxicology, in silico prediction, and endocrine disruption. The company was founded by David Leahy in 1999 and is headquartered in Abingdon, the United Kingdom. | Commercial Services |
Apex Molecular Ltd.
Apex Molecular Ltd. BiotechnologyHealth Technology Apex Molecular Ltd. provides chemistry research and experimental development services. Its services include custom/contract synthesis, targeted library synthesis, process optimisation and supply chain management. The company was founded in 2011 and is headquartered in Cheshire, the United Kingdom. | Health Technology |
